Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD8 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0008 | 0.05 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.5275 | 0.6322 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.3449 | 0.3905 |
Echinococcus multilocularis | cpg binding protein | 0.0036 | 0.4619 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0028 | 0.3449 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0028 | 0.3449 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.2223 | 0.6071 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0028 | 0.3449 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.004 | 0.5275 | 0.6322 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0021 | 0.2394 | 0.6421 |
Trypanosoma brucei | long-chain-fatty-acid-CoA ligase, putative | 0.0008 | 0.05 | 0.5 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.001 | 0.0819 | 0.0422 |
Schistosoma mansoni | acetyl-CoA synthetase | 0.0008 | 0.05 | 0.05 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.2223 | 0.6071 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.2394 | 0.2507 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.8052 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.2052 | 0.3767 |
Brugia malayi | CXXC zinc finger family protein | 0.0034 | 0.4331 | 0.5073 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0034 | 0.4331 | 0.5073 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.2052 | 0.2052 |
Mycobacterium tuberculosis | Peptide synthetase MbtF (peptide synthase) | 0.0008 | 0.05 | 0.0546 |
Trypanosoma brucei | acetyl-CoA synthetase, putative | 0.0008 | 0.05 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.2394 | 0.2507 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0008 | 0.0531 | 0.0531 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.3449 | 1 |
Mycobacterium tuberculosis | P-hydroxybenzoyl-AMP ligase FadD22 | 0.0008 | 0.05 | 0.0546 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0028 | 0.3449 | 1 |
Mycobacterium tuberculosis | Fatty-acid-CoA synthetase FadD17 (fatty-acid-CoA synthase) (fatty-acid-CoA ligase) | 0.0008 | 0.05 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.3449 | 0.3905 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0028 | 0.3449 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.3449 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.2394 | 0.2507 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.4619 | 0.4619 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.3449 | 0.3905 |
Mycobacterium ulcerans | hypothetical protein | 0.0028 | 0.3449 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0059 | 0.8052 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.3449 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0021 | 0.2394 | 0.6617 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.2052 | 0.2055 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.2223 | 0.6071 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD10 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0008 | 0.05 | 0.0546 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.2052 | 0.2052 |
Mycobacterium tuberculosis | Probable medium chain fatty-acid-CoA ligase FadD14 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0008 | 0.05 | 0.0546 |
Onchocerca volvulus | 0.0034 | 0.4331 | 1 | |
Schistosoma mansoni | cpg binding protein | 0.0034 | 0.4331 | 0.4331 |
Mycobacterium tuberculosis | Probable peptide synthetase Nrp (peptide synthase) | 0.0008 | 0.05 | 0.0546 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0028 | 0.3449 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0028 | 0.3449 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.2052 | 0.3767 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0059 | 0.8052 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.4619 | 0.4619 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0008 | 0.0531 | 0.0074 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.2052 | 0.2052 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.2052 | 0.2055 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0028 | 0.3449 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.2052 | 0.3767 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0008 | 0.05 | 0.5 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.001 | 0.0839 | 0.0822 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0008 | 0.05 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.2052 | 0.3767 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0028 | 0.3449 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0021 | 0.2394 | 1 |
Mycobacterium tuberculosis | Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase | 0.0008 | 0.05 | 0.0546 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD1 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0008 | 0.05 | 0.0546 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0008 | 0.0531 | 0.0074 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.0008 | 0.05 | 1 |
Loa Loa (eye worm) | histone methyltransferase | 0.001 | 0.0839 | 0.0449 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.2052 | 0.3767 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.2394 | 0.2507 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0021 | 0.2394 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0059 | 0.8052 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0036 | 0.4619 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0008 | 0.0531 | 0.0074 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0028 | 0.3449 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0021 | 0.2394 | 1 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.5275 | 0.5275 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0008 | 0.05 | 0.5 |
Onchocerca volvulus | 0.0028 | 0.3449 | 0.7697 | |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.2052 | 0.2055 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.001 | 0.0839 | 0.0822 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.2052 | 0.2055 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.3449 | 0.3905 |
Mycobacterium tuberculosis | Peptide synthetase MbtE (peptide synthase) | 0.0008 | 0.05 | 0.0546 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0028 | 0.3449 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.3449 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.2052 | 0.2052 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0008 | 0.0531 | 0.0074 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0008 | 0.05 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.3449 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.2394 | 0.2507 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.3449 | 0.3905 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0008 | 0.05 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.3449 | 0.3905 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.2223 | 0.6071 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.2052 | 0.3767 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.3449 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0064 | 0.8854 | 1 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.0008 | 0.05 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 32 ug ml-1 | In vitro minimum inhibitory concentration of the compound against Candida albicans | ChEMBL. | 15380214 |
MIC (functional) | = 32 ug ml-1 | In vitro minimum inhibitory concentration of the compound against Candida albicans | ChEMBL. | 15380214 |
MPC8 (functional) | = 2 ug ml-1 | In vitro minimum potentiation concentration to achieve an 8-fold reduction in fluconazole MIC against Candida glabrata strain YEM19 (over-expressing both CgDR1 and CgDR2) | ChEMBL. | 15380214 |
MPC8 (functional) | = 4 ug ml-1 | In vitro minimum potentiation concentration to achieve an 8-fold reduction in fluconazole MIC against Candida albicans strain YEM15 (over-expressing both CDR1 and CDR2) | ChEMBL. | 15380214 |
MPC8 (functional) | = 4 ug ml-1 | In vitro minimum potentiation concentration to achieve an 8-fold reduction in fluconazole MIC against Candida albicans strain YEM15 (over-expressing both CDR1 and CDR2) | ChEMBL. | 15380214 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.